MENU
LPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Leap Therapeutics (LPTX) Ownership - Who owns Leap Therapeutics?

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells... Show more

Profile

Industry
N/A
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
116.14M
P/E Ratio
N/A
Total Cash
18.13M
Projected Growth
N/A
Total Debt
39K
Revenue
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price